Literature DB >> 25786981

Prognostic evaluation of percentage variation of metabolic tumor burden calculated by dual-phase (18) FDG PET-CT imaging in patients with head and neck cancer.

Ronan Abgral1,2, Gérald Valette3, Philippe Robin1, Jean Rousset4, Nathalie Keromnes1, Pierre-Yves Le Roux1,2, Rémi Marianowski3, Pierre-Yves Salaün1,2.   

Abstract

BACKGROUND: The purpose of this study was to investigate the prognostic value of percentage variation of metabolic tumor burden in patients with head and neck squamous cell carcinoma (HNSCC).
METHODS: Patients referred to undergo (18) fluorodeoxyglucose (FDG) positron emission tomography (PET)-CT for staging of HNSCC were included in this study. Using a dual-phase method, standardized uptake value maximum (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were recorded and respectively used to calculate retention index (RI), %ΔMTV, and %ΔTLG. Recurrence-free survival (RFS) was determined by Kaplan-Meier method and compared with studied PET parameters in univariate and multivariate.
RESULTS: Seventy patients (61 men/9 women; 62.9 ± 9.1 years old) were included. In univariate, SUVmax, RI, MTV, and TLG (p ≤ .0001) were significantly correlated with RFS, unlike %ΔMTV (p = 137) and %ΔTLG (p = .517). In multivariate, RI (p = .005) and MTV (p = .022) persisted as independent prognostic factors.
CONCLUSION: Our results did not prove a prognostic interest of percentage variation of metabolic tumor burden in patients with HNSCC but confirmed that RI and MTV are independently correlated with RFS.
© 2015 Wiley Periodicals, Inc. Head Neck 38: E600-E606, 2016. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  dual-phase positron emission tomography (PET) imaging; head and neck squamous cell carcinoma; metabolic tumor burden; recurrence-free survival

Mesh:

Substances:

Year:  2015        PMID: 25786981     DOI: 10.1002/hed.24048

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  9 in total

1.  Regulation of glycolysis in head and neck squamous cell carcinoma.

Authors:  Dhruv Kumar
Journal:  Postdoc J       Date:  2017-01

2.  PET-based prognostic survival model after radiotherapy for head and neck cancer.

Authors:  Joël Castelli; A Depeursinge; A Devillers; B Campillo-Gimenez; Y Dicente; J O Prior; E Chajon; F Jegoux; C Sire; O Acosta; E Gherga; X Sun; B De Bari; J Bourhis; R de Crevoisier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-21       Impact factor: 9.236

3.  Clinical Outcomes of Surgically Managed Spontaneous Tumors in 114 Client-owned Dogs.

Authors:  Ji-Won Choi; Hun-Young Yoon; Soon-Wuk Jeong
Journal:  Immune Netw       Date:  2016-04-28       Impact factor: 6.303

4.  The maximum standardized uptake value increment calculated by dual-time-point 18F-fluorodeoxyglucose positron emission tomography predicts survival in patients with oral tongue squamous cell carcinoma.

Authors:  Natsuki Yonezawa; Tsutomu Minamikawa; Kazuhiro Kitajima; Yusuke Takahashi; Ryohei Sasaki; Ken-Ichi Nibu; Takahide Komori
Journal:  Nagoya J Med Sci       Date:  2017-02       Impact factor: 1.131

5.  Inter-observer and segmentation method variability of textural analysis in pre-therapeutic FDG PET/CT in head and neck cancer.

Authors:  Catherine Guezennec; David Bourhis; Fanny Orlhac; Philippe Robin; Jean-Baptiste Corre; Olivier Delcroix; Yves Gobel; Ulrike Schick; Pierre-Yves Salaün; Ronan Abgral
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

6.  Feasibility Study and Preliminary Results of Prognostic Value of Bone SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma to Abiraterone.

Authors:  Romain de Laroche; David Bourhis; Philippe Robin; Olivier Delcroix; Solène Querellou; Jean-Pierre Malhaire; Friederike Schlurmann; Vincent Bourbonne; Pierre-Yves Salaün; Ulrike Schick; Ronan Abgral
Journal:  Front Med (Lausanne)       Date:  2020-01-22

7.  Comparison of Volumetric Quantitative PET Parameters Before and After a CT-Based Elastic Deformation on Dual-Time 18FDG-PET/CT Images: A Feasibility Study in a Perspective of Radiotherapy Planning in Head and Neck Cancer.

Authors:  Meriem Maajem; Jean-Christophe Leclère; David Bourhis; Valentin Tissot; Nicolas Icard; Laëtitia Arnaud; Romain Le Pennec; Gurvan Dissaux; Dorothy M Gujral; Pierre-Yves Salaün; Ulrike Schick; Ronan Abgral
Journal:  Front Med (Lausanne)       Date:  2022-02-11

8.  Prognostic value of the standardized uptake value maximum change calculated by dual-time-point (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with advanced non-small-cell lung cancer.

Authors:  Feng Jin; Hui Zhu; Zheng Fu; Li Kong; Jinming Yu
Journal:  Onco Targets Ther       Date:  2016-05-19       Impact factor: 4.147

9.  Dual time-point 18F-FDG PET/CT imaging with multiple metabolic parameters in the differential diagnosis of malignancy-suspected bone/joint lesions.

Authors:  Chen-Tian Shen; Zhong-Ling Qiu; Zhen-Kui Sun; Wei-Jun Wei; Hong-Jun Song; Xin-Yun Zhang; Quan-Yong Luo
Journal:  Oncotarget       Date:  2017-04-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.